Dexcom Q2 revenue $696.2M (+17% YoY); GAAP EPS $0.12, Non-GAAP EPS $0.17

DEXCOM INC

2022-Q2 EPS reported $0.36 revenue$1,325,000,000

Revenue $696.2M, +17% reported, +16% organic; U.S. +11%, international +39% reported (+34% organic).
GAAP operating margin 11.1% (down 590bps); Non-GAAP operating margin 14.6% (down 250bps).
GAAP net income $50.9M ($0.12 diluted EPS); Non-GAAP net income $69.5M ($0.17 diluted EPS).
FY2022 guidance: revenue $2.86-2.91B (17-19% growth); Non-GAAP gross margin ~65%, op margin ~16%, Adj. EBITDA ~25%.
Launched Dexcom ONE in UK/Spain; received CE Mark for G7 sensor algorithm; launched Spanish-language G6 app.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.